Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell D Cohen

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Journal of Gastroenterology and Hepatology|June 7, 2019
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remissionYunwei Wang, Jennifer Wang, Joel Pekow, et al.
Digestive Diseases and Sciences|October 15, 2022
Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical OutcomesNathaniel A Cohen, Joshua M Steinberg, Alexa Silfen, et al.
Therapeutic Advances in Gastroenterology|September 11, 2023
Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitisOmar K Jamil, Dustin Shaw, Zifeng Deng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 10, 2023
Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World ExperienceScott Friedberg, David Choi, Thomas Hunold, et al.
Diseases of the Colon and Rectum|December 13, 2018
Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic PatientsPhilip H Sossenheimer, Laura R Glick, Abraham H Dachman, et al.
Gastrointestinal Endoscopy|February 10, 2019
Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's diseaseJacob E Ollech, Maya Aharoni-Golan, Roni Weisshof, et al.
Digestion|February 8, 2021
The Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn's DiseaseAkihiro Yamada, Yuga Komaki, Fukiko Komaki, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2018
A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's diseaseAdjoa Anyane-Yeboa, Akihiro Yamada, Haider Haider, et al.
Clinical and Translational Science|November 24, 2025
Colonic Tissue Expression of MAdCAM-1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel DiseaseNikhil Reddy, Jeremy A Klein, Nikita Thomas, et al.
The American Journal of Gastroenterology|July 19, 2017
Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With VedolizumabAkihiro Yamada, Yuga Komaki, Nayan Patel, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Journal of Gastroenterology and Hepatology|June 7, 2019
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remissionYunwei Wang, Jennifer Wang, Joel Pekow, et al.
Digestive Diseases and Sciences|October 15, 2022
Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical OutcomesNathaniel A Cohen, Joshua M Steinberg, Alexa Silfen, et al.
Therapeutic Advances in Gastroenterology|September 11, 2023
Inflammation in the proximal colon is a risk factor for the development of colorectal neoplasia in inflammatory bowel disease patients with primary sclerosing cholangitisOmar K Jamil, Dustin Shaw, Zifeng Deng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 10, 2023
Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World ExperienceScott Friedberg, David Choi, Thomas Hunold, et al.
Diseases of the Colon and Rectum|December 13, 2018
Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic PatientsPhilip H Sossenheimer, Laura R Glick, Abraham H Dachman, et al.
Gastrointestinal Endoscopy|February 10, 2019
Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's diseaseJacob E Ollech, Maya Aharoni-Golan, Roni Weisshof, et al.
Digestion|February 8, 2021
The Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn's DiseaseAkihiro Yamada, Yuga Komaki, Fukiko Komaki, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2018
A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's diseaseAdjoa Anyane-Yeboa, Akihiro Yamada, Haider Haider, et al.
Clinical and Translational Science|November 24, 2025
Colonic Tissue Expression of MAdCAM-1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel DiseaseNikhil Reddy, Jeremy A Klein, Nikita Thomas, et al.
The American Journal of Gastroenterology|July 19, 2017
Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With VedolizumabAkihiro Yamada, Yuga Komaki, Nayan Patel, et al.
Pageof 11